Rani Therapeutics Holdings, Inc.
NASDAQ: RANI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Talat Imran
- Employees
- 105
- Headquarters
- San Jose, United States
- IPO year
- 2021
- Market cap
- $50.1M
- Website
- https://www.ranitherapeutics.com
Loading RANI…
Loading profile data…Frequently asked questions about RANI
What does Rani Therapeutics Holdings, Inc. (RANI) do?
Rani Therapeutics Holdings, Inc. functions as a clinical-stage biopharmaceutical enterprise focused on revolutionizing the delivery of biologic therapies through oral administration. Its flagship innovation, the RaniPill capsule, aims to supplant conventional subcutaneous or intravenous injections of biologics with a more convenient oral dosing...
Where does RANI trade?
Rani Therapeutics Holdings, Inc. (RANI) trades on the NASDAQ Global Market.
What sector is RANI in?
Rani Therapeutics Holdings, Inc. (RANI) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Rani Therapeutics Holdings, Inc.?
Talat Imran is the chief executive officer of Rani Therapeutics Holdings, Inc. (RANI).
Where is Rani Therapeutics Holdings, Inc. headquartered?
Rani Therapeutics Holdings, Inc. is headquartered in United States.
Does RANI pay a dividend?
Rani Therapeutics Holdings, Inc. (RANI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RANI go public?
Rani Therapeutics Holdings, Inc. (RANI) completed its initial public offering in 2021.